Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 11, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 13 May 2025 - 15:45

Human medicines European public assessment report (EPAR): Kanjinti, trastuzumab, Date of authorisation: 16/05/2018, Revision: 11, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/kanjinti

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters